MarginBio

Biotechnology Research • St Paul, Minnesota, United States • 1-10 Employees

Company overview

Headquarters	1000 Westgate Dr, St Paul, Minnesota 55114, US
Website	marginbio.com
NAICS	541714
Keywords	VHH, Membrane Proteins, Biomolecular Display, Darpins
Founded	2021
Employees	1-10

Key Contact at MarginBio

Igor Dodevski

Founder and Managing Director

MarginBio Email Formats

MarginBio uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@marginbio.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@marginbio.com	100%

About MarginBio

MarginBio is a startup company developing innovative display technology to discover protein biologics that engage challenging target epitopes. We are focusing our discovery platform on multispan membrane proteins that are natively expressed on whole cells, eliminating the need for antigen purification.

MarginBio revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

MarginBio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

MarginBio has never raised funding before.

Frequently asked questions

MarginBio is located in St Paul, Minnesota, US.

MarginBio was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

MarginBio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at MarginBio

Igor Dodevski

Founder and Managing Director

4.8

40,000 users